Announced Mon, 29 Jun · 10:19 IST
Trading window closure from July 1, 2026 till Q1FY27 results announcement
Compliance View source PDF
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-5.2%1-day move
₹91.79
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-5.2-3.4-2.5-3.1-5.1-5.8-2.6———
Up moveDown movePending
AI summary
Indo Us Biotech has informed exchanges that its trading window will remain closed from Wednesday, July 1, 2026 till 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026. The closure is a routine compliance requirement under SEBI insider trading regulations and applies to designated persons of the company.
Likely market impact
Routine regulatory filing; signals that Q1FY27 results are upcoming. No direct material impact on the stock.